Alexza Pharmaceuticals Inc. is a pharmaceutical company that specializes in research and development of drugs that treat central nervous system conditions. One of Alexza’s most well known products is Stoccato nicotine, a vaporized drug that helps smokers by catering to the chemical and behavioral components of quitting. They are also in the process of developing a painkiller that would help cancer patients and patients with acute pain episodes.

Alexza can expect to hear the results of their marketing application from the FDA within a couple of weeks. Their marketing application was delayed after the FDA cited issues with its Mountain View, California manufacturing facility.

David Cornes holds a degree in economics from the University of Montana.